We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CMRX market cap is 80.51M. The company's latest EPS is USD -0.9159 and P/E is -0.98.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 283k | 26k | 11k | 4k | 0 |
| Operating Income | -24.22M | -21.35M | -26.69M | -20.81M | -24.39M |
| Net Income | -21.37M | -18.58M | -23.99M | -18.16M | -21.87M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 12.52M | 5.37M | 1.98M | 33.82M | 324k |
| Operating Income | -115.98M | -44.52M | -173.4M | -60.39M | -93.07M |
| Net Income | -112.58M | -43.52M | -173.24M | 172.17M | -82.1M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 258.53M | 241.09M | 225.28M | 212.77M | 194.04M |
| Total Liabilities | 18.22M | 16.97M | 16.98M | 19.75M | 19.94M |
| Total Equity | 240.31M | 224.11M | 208.3M | 193.03M | 174.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 119.38M | 84.72M | 100.54M | 279.34M | 212.77M |
| Total Liabilities | 9.42M | 11.35M | 32.29M | 22.48M | 19.75M |
| Total Equity | 109.95M | 73.38M | 68.25M | 256.86M | 193.03M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.23M | -36.57M | -54.5M | -69.09M | -17.52M |
| Investing | 12.14M | 30.66M | 42.53M | 70.6M | 8.68M |
| Financing | 199k | 168k | 246k | 308k | 208k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -75.18M | -36.04M | -99.93M | -46.87M | -69.09M |
| Investing | 10.63M | 64.71M | -44.09M | 70.04M | 70.6M |
| Financing | 345k | 1.41M | 112.43M | -12.73M | 308k |
| Market Cap | 80.51M |
| Price to Earnings Ratio | -0.98 |
| Price to Sales Ratio | 250 |
| Price to Cash Ratio | 2.92 |
| Price to Book Ratio | 0.42 |
| Dividend Yield | - |
| Shares Outstanding | 89.63M |
| Average Volume (1 week) | 315.16k |
| Average Volume (1 Month) | 239.35k |
| 52 Week Change | -35.84% |
| 52 Week High | 1.405 |
| 52 Week Low | 0.87 |
| Spread (Intraday) | 0.38 (31.4%) |
| Company Name | Chimerix Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.chimerix.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
